Free Trial

APG Asset Management N.V. Takes $7.92 Million Position in Revvity, Inc. (NYSE:RVTY)

Revvity logo with Medical background
Remove Ads

APG Asset Management N.V. purchased a new stake in Revvity, Inc. (NYSE:RVTY - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 73,474 shares of the company's stock, valued at approximately $7,919,000. APG Asset Management N.V. owned about 0.06% of Revvity at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of RVTY. Norges Bank acquired a new position in shares of Revvity during the 4th quarter valued at about $127,801,000. Invesco Ltd. boosted its stake in Revvity by 18.8% in the 4th quarter. Invesco Ltd. now owns 1,740,933 shares of the company's stock valued at $194,306,000 after purchasing an additional 274,923 shares during the period. Proficio Capital Partners LLC boosted its stake in shares of Revvity by 12,298.3% in the 4th quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company's stock valued at $21,850,000 after purchasing an additional 194,190 shares in the last quarter. ExodusPoint Capital Management LP bought a new position in shares of Revvity during the fourth quarter worth about $20,735,000. Finally, Vanguard Group Inc. grew its stake in Revvity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 14,290,211 shares of the company's stock valued at $1,594,930,000 after acquiring an additional 156,679 shares during the period. Institutional investors own 86.65% of the company's stock.

Insider Transactions at Revvity

In related news, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the sale, the insider now directly owns 33,400 shares in the company, valued at approximately $4,232,782. This represents a 31.23 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.68% of the stock is currently owned by corporate insiders.

Remove Ads

Wall Street Analyst Weigh In

Several research analysts have commented on RVTY shares. Raymond James reissued an "outperform" rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Barclays lowered their price objective on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Sanford C. Bernstein downgraded shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target for the company. in a research report on Friday, January 10th. Finally, KeyCorp boosted their target price on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Four equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $133.75.

Check Out Our Latest Report on RVTY

Revvity Stock Down 1.1 %

Shares of RVTY stock traded down $1.02 on Wednesday, reaching $94.52. 523,763 shares of the stock were exchanged, compared to its average volume of 886,636. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $11.36 billion, a price-to-earnings ratio of 42.77, a PEG ratio of 3.82 and a beta of 1.07. The business's 50 day moving average price is $108.15 and its 200 day moving average price is $114.76. Revvity, Inc. has a twelve month low of $89.61 and a twelve month high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter in the prior year, the firm earned $1.25 earnings per share. As a group, sell-side analysts expect that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity's dividend payout ratio (DPR) is currently 12.67%.

About Revvity

(Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Featured Articles

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Should You Invest $1,000 in Revvity Right Now?

Before you consider Revvity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.

While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads